Atea Pharmaceuticals(AVIR) - 2022 Q2 - Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President of Investor Relations & Corporate Communications Jean-Pierre Sommadossi - Chief Executive Officer & Founder Janet Hammond - Chief Development Officer Andrea Corcoran - Chief Financial Officer & Executive President of Legal John Vavricka - Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair Nik Gasic - SVB Securities Operator ...